» Articles » PMID: 32336304

Prevalence and Incidence of Clinical Outcomes in Patients Presenting to Secondary Mental Health Care with Mood Instability and Sleep Disturbance

Overview
Journal Eur Psychiatry
Specialty Psychiatry
Date 2020 Apr 28
PMID 32336304
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mood instability and sleep disturbance are common symptoms in people with mental illness. Both features are clinically important and associated with poorer illness trajectories. We compared clinical outcomes in people presenting to secondary mental health care with mood instability and/or sleep disturbance with outcomes in people without either mood instability or sleep disturbance.

Methods: Data were from electronic health records of 31,391 patients ages 16-65 years presenting to secondary mental health services between 2008 and 2016. Mood instability and sleep disturbance were identified using natural language processing. Prevalence of mood instability and sleep disturbance were estimated at baseline. Incidence rate ratios were estimates for clinical outcomes including psychiatric diagnoses, prescribed medication, and hospitalization within 2-years of presentation in persons with mood instability and/or sleep disturbance compared to individuals without either symptom.

Results: Mood instability was present in 9.58%, and sleep disturbance in 26.26% of patients within 1-month of presenting to secondary mental health services. Compared with individuals without either symptom, those with mood instability and sleep disturbance showed significantly increased incidence of prescription of any psychotropic medication (incidence rate ratios [IRR] = 7.04, 95% confidence intervals [CI] 6.53-7.59), and hospitalization (IRR = 5.32, 95% CI 5.32, 4.67-6.07) within 2-years of presentation. Incidence rates of most clinical outcomes were considerably increased among persons with both mood instability and sleep disturbance, relative to persons with only one symptom.

Conclusions: Mood instability and sleep disturbance are present in a wide range of mental disorders, beyond those in which they are conventionally considered to be symptoms. They are associated with poor outcomes, particularly when they occur together. The poor prognosis associated with mood instability and sleep disorder may be, in part, because they are often treated as secondary symptoms. Mood instability and sleep disturbance need better recognition as clinical targets for treatment in their own right.

Citing Articles

Mood instability and risk of gastrointestinal diseases - a univariable and multivariable mendelian randomization study.

Liu R, Song Q, Liu L, Yang Y, Zhu W Ann Gen Psychiatry. 2024; 23(1):50.

PMID: 39702383 PMC: 11660901. DOI: 10.1186/s12991-024-00537-7.


A survey on clinical natural language processing in the United Kingdom from 2007 to 2022.

Wu H, Wang M, Wu J, Francis F, Chang Y, Shavick A NPJ Digit Med. 2022; 5(1):186.

PMID: 36544046 PMC: 9770568. DOI: 10.1038/s41746-022-00730-6.


Aggressive challenging behavior in adults with intellectual disability: An electronic register-based cohort study of clinical outcome and service use.

Smith J, Baksh R, Hassiotis A, Sheehan R, Ke C, Wong T Eur Psychiatry. 2022; 65(1):e74.

PMID: 36321353 PMC: 9706303. DOI: 10.1192/j.eurpsy.2022.2336.


Natural language processing in clinical neuroscience and psychiatry: A review.

Crema C, Attardi G, Sartiano D, Redolfi A Front Psychiatry. 2022; 13:946387.

PMID: 36186874 PMC: 9515453. DOI: 10.3389/fpsyt.2022.946387.


NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data.

Patel R, Wee S, Ramaswamy R, Thadani S, Tandi J, Garg R BMJ Open. 2022; 12(4):e057227.

PMID: 35459671 PMC: 9036423. DOI: 10.1136/bmjopen-2021-057227.


References
1.
Wilson S, Anderson K, Baldwin D, Dijk D, Espie A, Espie C . British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol. 2019; 33(8):923-947. DOI: 10.1177/0269881119855343. View

2.
Sheaves B, Freeman D, Isham L, McInerney J, Nickless A, Yu L . Stabilising sleep for patients admitted at acute crisis to a psychiatric hospital (OWLS): an assessor-blind pilot randomised controlled trial. Psychol Med. 2017; 48(10):1694-1704. PMC: 6088775. DOI: 10.1017/S0033291717003191. View

3.
McDonald K, Saunders K, Geddes J . Sleep problems and suicide associated with mood instability in the Adult Psychiatric Morbidity Survey, 2007. Aust N Z J Psychiatry. 2017; 51(8):822-828. PMC: 5947783. DOI: 10.1177/0004867416687398. View

4.
Marwaha S, Broome M, Bebbington P, Kuipers E, Freeman D . Mood instability and psychosis: analyses of British national survey data. Schizophr Bull. 2013; 40(2):269-77. PMC: 3932088. DOI: 10.1093/schbul/sbt149. View

5.
Harvey A . A transdiagnostic approach to treating sleep disturbance in psychiatric disorders. Cogn Behav Ther. 2009; 38 Suppl 1:35-42. DOI: 10.1080/16506070903033825. View